BIM
ARRY

Bogle Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Bogle Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-366,626
Closed -$5.98M – 390
2018
Q1 		$5.98M Buy
+366,626
New +$5.87M 0.45% 88
2017
Q2 		– Sell
-1,995,880
Closed -$17.8M – 422
2017
Q1 		$17.8M Sell
1,995,880
-77,800
-4% -$828K 1.24% 7
2016
Q4 		$18.2M Buy
2,073,680
+796,466
+62% +$5.86M 1.26% 4
2016
Q3 		$8.62M Buy
+1,277,214
New +$4.94M 0.62% 64
2016
Q1 		– Sell
-211,714
Closed -$893K – 505
2015
Q4 		$893K Buy
+211,714
New +$966K 0.06% 278
2015
Q2 		– Sell
-1,450,173
Closed -$10.7M – 459
2015
Q1 		$10.7M Buy
+1,450,173
New +$10.3M 0.74% 45

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bogle Investment Management's ARRY Position: Q2 2018 in Review

Bogle Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 366,626 shares — an estimated $5.98M sold.

Bogle Investment Management first reported a position in ARRY in Q1 2015 and held it in 6 quarters. The position peaked at $18.2M in Q4 2016. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Bogle Investment Management reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Bogle Investment Management sold 366,626 Array Biopharma Inc shares in Q2 2018, an estimated $5.98M.
  • Bogle Investment Management first reported a position in Array Biopharma Inc in Q1 2015 and held it in 6 quarters.
  • Bogle Investment Management's Array Biopharma Inc position peaked at $18.2M in Q4 2016.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Bogle Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.